Suppr超能文献

用于治疗单纯性打鼾的腭柱植入物。

Palatal Pillar implants for the treatment of simple snoring.

作者信息

Sezen Ozan Seymen, Kaytanci Hande, Salepçi Banu, Yurteri Gülfem, Kubilay Utku, Coşkuner Temel, Cağlayan Benan, Unver Seref

机构信息

Department of 1st Otolaryngology, Kartal Dr. Lütfi Kirdar Training and Research Hospital, Istanbul, Turkey.

出版信息

Kulak Burun Bogaz Ihtis Derg. 2009 Sep-Oct;19(5):239-45.

Abstract

OBJECTIVES

In this study the efficacy of palatal implants for treatment of snoring was evaluated.

PATIENTS AND METHODS

Seventeen patients (10 males, 7 females; mean age 49.2+/-7.8 years; range 31 to 66 years) with primary snoring and an apnea-hypopnea index of less than 15 were treated with palatal implants after clinical and endoscopic examination. Snoring-related symptoms were evaluated at baseline and 90 days after surgery and polysomnography was performed. Patients and their spouses completed questionnaires and visual analog scales (VAS) evaluating snoring, apneas, and the intensity, duration, and social effects of daytime sleepiness at baseline and 90 days after surgery. Pre- and postoperative assessment results were compared.

RESULTS

Epworth sleepiness scale score was significantly decreased in the postoperative period (p<0.05). Postoperative mean VAS snoring, apnea, and daytime sleepiness scores were also significantly improved (p<0.01). No patients reported worsening of apnea, 5.9% of patients reported no change in apnea, and 94.1% of patients reported a marked decrease in apneas. In the postoperative period, 76.4% of patients reported reduced snoring, and 88.3% of patients reported reduced daytime sleepiness.

CONCLUSION

Palatal implants have been demonstrated to be a safe and effective treatment for snoring with minimal patient discomfort. Establishing realistic pretreatment expectations can maximize patient satisfaction.

摘要

目的

本研究评估了腭部植入物治疗打鼾的疗效。

患者与方法

17例患者(10例男性,7例女性;平均年龄49.2±7.8岁;范围31至66岁),患有原发性打鼾且呼吸暂停低通气指数小于15,在临床和内镜检查后接受腭部植入物治疗。在基线和手术后90天评估与打鼾相关的症状,并进行多导睡眠图检查。患者及其配偶在基线和手术后90天完成问卷和视觉模拟量表(VAS),评估打鼾、呼吸暂停以及白天嗜睡的强度、持续时间和社会影响。比较术前和术后的评估结果。

结果

术后Epworth嗜睡量表评分显著降低(p<0.05)。术后VAS打鼾、呼吸暂停和白天嗜睡的平均评分也显著改善(p<0.01)。没有患者报告呼吸暂停加重,5.9%的患者报告呼吸暂停无变化,94.1%的患者报告呼吸暂停明显减少。在术后期间,76.4%的患者报告打鼾减轻,88.3%的患者报告白天嗜睡减轻。

结论

腭部植入物已被证明是一种治疗打鼾的安全有效的方法,患者不适最小。建立现实的术前预期可以最大限度地提高患者满意度。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验